Radiotherapy Department, Interbalkan Medical Center, 10 Asclepioustr, 57001 Pylaia, Thessaloniki, Greece.
Clinic of Hospital Dentistry, Dental School, National and Kapodistrian University of Athens, 2 Thivonstr, Goudi, 11527Athens, Greece.
Rev Recent Clin Trials. 2021;16(2):151-165. doi: 10.2174/1574887115666200731182708.
Backround: Radiation-induced oral mucositis consists of a series of relatively frequent side effects after head and neck cancer radiotherapy and has an adverse impact on both regular treatment process and the quality of life of patients.
The purpose of the present review is to optimize the current management of radiation-induced oral mucositis in head and neck cancer patients.
PubMed database research was performed on articles published since 2015 that demonstrated efficacy in the management of radiation-induced oral mucositis in head and neck cancer patients. The study selection included observational, prospective, comparative, randomized, double- blind, placebo-controlled or uncontrolled, and retrospective studies, as well as systematic reviews and metanalyses.
From the 931 citations obtained from the search, only 94 articles met the inclusion criteria, including mucosal protectants, anti-inflammatory agents, growth factors, and various miscellaneous and natural agents. Several methods, including both pharmacological and natural agents, have been proposed for the management of oral mucositis. In addition to the already known interventions with strong evidence, according to the Multinational Association of Supportive Care in Cancer and he International Society of Oral Oncology guidelines, further agents have been used. However, a great number of them lack clear evidence, which surely requires the design of more controlled clinical trials for a better assessment of the ideal methods.
The management of oral mucositis constitutes an active area of research. In light of these results, it is aimed to illustrate those treatment strategies that are most effective regarding the treatment approach of oral mucositis.
放射性口腔黏膜炎是头颈部癌症放射治疗后一系列相对常见的副作用,对常规治疗过程和患者的生活质量都有不良影响。
本综述的目的是优化头颈部癌症患者放射性口腔黏膜炎的当前管理。
对 2015 年以来发表的在头颈部癌症患者中展示放射性口腔黏膜炎管理疗效的文章,在 PubMed 数据库中进行研究。研究选择包括观察性、前瞻性、比较性、随机、双盲、安慰剂对照或非对照和回顾性研究,以及系统评价和荟萃分析。
从搜索中获得的 931 条引文,只有 94 篇文章符合纳入标准,包括黏膜保护剂、抗炎剂、生长因子和各种杂项和天然药物。已经提出了几种治疗口腔黏膜炎的方法,包括药理学和天然药物。除了已经具有强证据的已知干预措施外,根据多国支持治疗癌症协会和国际口腔肿瘤协会的指南,还使用了其他一些药物。然而,其中许多药物缺乏明确的证据,这确实需要设计更多的对照临床试验,以便更好地评估理想的方法。
口腔黏膜炎的管理是一个活跃的研究领域。基于这些结果,旨在说明那些针对口腔黏膜炎治疗方法最有效的治疗策略。